main content start
Tresiba U-100 (insulin degludec) injection is an ultra-long-acting insulin for adults and children 1 year and older with diabetes. It is injected daily via syringe or the prefilled disposable Tresiba FlexTouch pen. It is also available in a higher concentration U-200 FlexTouch pen.
- Ultra-long-acting Insulin: Covers full day insulin needs. Usually begins to work several hours after injection and lasts for up to 42 hours.
- It is injected daily via syringe or the prefilled disposable Tresiba FlexTouch pen.
- Approved for adults and children 1 year and older with diabetes.
- Tresiba U-100 FlexTouch is a blue pen. It delivers doses in 1 unit increments, up to 80 units at a time. It has a total capacity of 300 units.
- Tresiba U-100 FlexTouch has audible clicks during dosing. This helps people with visual impairment or manual dexterity issues select the correct dose.
- It is also available in a higher concentration U-200 FlexTouch pen.
Tresiba U-100 Specs
Key specification
Generic Name
Insulin degludec
Onset
Not Applicable
Peak
No peak
Duration
42 hours
Approved for Kids
1+
Audible Clicks During Dosing
Yes
Color
Blue pen
Concentration
U-100
Delivery
Syringe; Pen
Insulin Type
Ultra-long-acting
Form
Analog
General Information
Product Name
Tresiba U-100
Product Type
Insulin
Brand
Novo Nordisk
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
